A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency

Kaori Suzuki, Juan Fueyo, Victor Krasnykh, Paul N. Reynolds, David T. Curiel, Ramon Alemany

Research output: Contribution to journalArticlepeer-review

225 Scopus citations

Abstract

The absence or the presence of low levels of the Coxsackievirus and adenovirus receptor (CAR) on several tumor types might limit the efficacy of recently proposed tumor-specific or conditionally replicative adenoviruses (CRAds). To address this issue, we used a genetic modification of the fiber knob in the context of an E1A-defective CRAd to allow CAR-independent target cell infection as a means to enhance oncolytic potency. Such infectivity-enhanced CRAd showed higher replication, more efficient infection, and lysis of tumor cells in vitro. Of note, the improved antitumor effect of the fiber-modified CRAd could be demonstrated in vivo. We conclude that the combination of genomic modification to achieve tumor-selective replication and capsid modification to enhance infectivity yields more potent oncolytic adenoviruses for use in cancer treatment.

Original languageEnglish
Pages (from-to)120-126
Number of pages7
JournalClinical Cancer Research
Volume7
Issue number1
StatePublished - Jan 2001
Externally publishedYes

Fingerprint Dive into the research topics of 'A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency'. Together they form a unique fingerprint.

Cite this